Our Investment Centre
SeaDragon believes it has a unique opportunity to capitalise on the deep blue and clean waters of New Zealand and the South Pacific to become a regional leader in the production of ocean-sourced Omega-3 bioactive compounds.
SeaDragon Limited is listed on the New Zealand Stock Exchange (NZX:SEA) and is New Zealand’s largest refiner and blender of high-quality, internationally certified concentrated fish oils and fractions, including Omega-3 oils.
Our oils are sourced from fish caught in the clean and pure waters around New Zealand, in the Southern Ocean, and elsewhere. We supply health supplement manufacturers around the world to meet the burgeoning demand for pure, high-quality fish oils, which are scientifically proven to deliver significant human health benefits such as lowering the risk of heart disease, improving brain function and joint health. The majority of our supply is exported.
SeaDragon has a waiver that was granted by NZX Regulation on 2 December 2015 in relation to a supply agreement entered into with shareholder Comvita Limited (Comvita).
For full details of the waiver click here
Takeovers Code Disclosures
The Takeovers Code requires the following disclosure in relation to the convertible loan note and or options granted to BioScience Managers, Comvita and Pescado
For full details of the disclosure click here
Takeovers Code Update
Previously issued convertible loan notes will convert into ordinary shares in SeaDragon (NZX:SEA) at 5:00 p.m. on 31 March 2020, resulting in the issue of 9,090,909 ordinary shares to each of Pescado, Comvita and BioScience.
For full details of this share issue click here
Corporate governance statement
Our statements of corporate governance are published in our Annual Report, a copy can be download from the link below.